Novartis backs Matchpoint with $1B pact to unlock covalent immunology The deal reflects growing interest in covalent chemistry as a solution for “undruggable” inflammatory proteins.

https://www.drugdiscoverynews.com/novartis-backs-matchpoint-with-1b-pact-to-unlock-covalent-immunology-16546